Bioasis Technologies Inc. (BIOAF) Financials

BIOAF Assets vs Liabilities

DateAssetsLiabilities
Nov. 30, 2022 1.3 million 3.3 million
Aug. 31, 2022 1.8 million 3.1 million
May 31, 2022 1.0 million 2.7 million
Feb. 28, 2022 1.8 million 3.3 million

BIOAF Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Nov. 30, 2022 -326875 2819
Aug. 31, 2022 -171051 191944
May 31, 2022 -464876 2920
Feb. 28, 2022 -531551 7588

BIOAF Net Income

No data available :(

BIOAF Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Nov. 30, 2022 115407 526174 -
Aug. 31, 2022 434518 385153 -
May 31, 2022 603869 215788 -
Feb. 28, 2022 1.4 million 313761 -

BIOAF Shares Outstanding

No data available :(

BIOAF Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Nov. 30, 2022 - 162848 462282 -
Aug. 31, 2022 - 187981 592082 -
May 31, 2022 - 142897 354151 -
Feb. 28, 2022 - 250806 409760 -

BIOAF Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Nov. 30, 2022 109819 162848
Aug. 31, 2022 92099 23951
May 31, 2022 - 10662
Feb. 28, 2022 - 10664

BIOAF

Price: $0

52 week price:
0.00
0.00

Earnings Per Share: -0.01 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 7941

Links: